Core Insights - The company held an earnings briefing on September 19, 2025, to address investor inquiries regarding its business prospects and technological capabilities [1]. Group 1: Market Potential and Business Strategy - The brain-machine interface market is expected to grow significantly over the next three years, supported by technological advancements, demand from an aging population, and policy backing, although the company's future revenue contribution from this segment remains uncertain [2][4]. - The company emphasizes its core technology in multi-modal BioCV (biometric recognition and computer vision) and other advanced technologies, creating a competitive edge through a closed-loop system of technology, research, products, and market [2][3]. Group 2: Financial Performance - For the first half of 2025, the company reported a main revenue of 929 million yuan, a year-on-year increase of 2.9%, and a net profit attributable to shareholders of 93.24 million yuan, up 18.56% [5]. - The company's net profit growth outpaced revenue growth due to an increase in export sales, reduced sales expenses, and lower financial costs from exchange gains [3][5]. Group 3: International Operations and Product Development - 76% of the company's revenue comes from overseas markets, with significant growth in regions such as the Americas, Asia-Pacific, Middle East, and Europe, primarily from smart space technology products and solutions [3][5]. - The company is advancing its brain-machine interface business, focusing on emotion analysis, with a prototype expected to be launched by March 2026 [4].
熵基科技:9月19日召开业绩说明会,投资者参与